Articles published by Supernus Pharmaceuticals, Inc.
Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
February 27, 2024
Supernus Announces Third Quarter 2023 Financial Results
November 08, 2023
Supernus to Participate in the Jefferies London Healthcare Conference
November 07, 2023
Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
October 09, 2023
Supernus Announces New Qelbree® Data Showing Improvement in ADHD Symptoms
September 09, 2023
Supernus to Participate in the Wells Fargo Healthcare Conference
August 31, 2023
Bethany L. Sensenig Joins Supernus’ Board of Directors
August 21, 2023
Supernus Announces Second Quarter 2023 Financial Results
August 08, 2023
Supernus Announces Repayment of Convertible Notes
April 03, 2023
Supernus to Participate in Two Upcoming Investor Conferences
March 08, 2023
Supernus Announces Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023
Supernus Enters Into $150 Million Credit Facility
February 14, 2023
Supernus to Present at Two November Healthcare Conferences
November 08, 2022
Supernus Announces Third Quarter 2022 Financial Results
November 08, 2022
Supernus Provides Regulatory Update on SPN-830
October 10, 2022
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.